Healthcare Aug 26, 2021 04:05 PM (GMT+8) · EqualOcean
Financial Associated Press, August 26 - Lianhua technology announced that in order to further sort out the pharmaceutical business of Lianhua Technology Co., Ltd. (hereinafter referred to as "the company"), strengthen the pharmaceutical business of the company and improve the overall governance level of the company, Lianhua Technology (Taizhou) Co., Ltd. (hereinafter referred to as "Taizhou Lianhua"), a wholly-owned subsidiary of the company, is now integrating some assets of non pharmaceutical business Creditor's rights, debts and related personnel are transferred to Lianhua science and technology new material (Taizhou) Co., Ltd., a wholly-owned subsidiary (hereinafter referred to as "Lianhua new material"), and the management of the company is authorized to handle matters related to this asset transfer.

This text is a result of machine translation.